Literature DB >> 8104317

Hypotensive and bradycardic effects of talipexole (B-HT 920) in anaesthetized rabbits are antagonized by metoclopramide but not by yohimbine.

R Palluk1, J C Schilling, K Stockhaus, H Peil.   

Abstract

The interactions of talipexole (B-HT 920) and clonidine with selective alpha-adrenoceptor antagonists, yohimbine (alpha 2) and prazosin (alpha 1), as well as with dopamine receptor antagonists, metoclopramide (D2), domperidone (D2) and SCH23,390 (D1) were investigated in anaesthetized rabbits after i.v. administration. Both talipexole (0.03-0.1 mg/kg) and clonidine (0.01-0.03 mg/kg) dose-dependently induced hypotension and bradycardia. Talipexole had a shorter duration of action. The hypotensive effect of the alpha 2-adrenoceptor and D2 agonist talipexole (0.03 mg/kg) was antagonized by pretreatment with metoclopramide (3 mg/kg) or domperidone (0.3-3 mg/kg), but not with yohimbine (3 mg/kg), prazosin (0.1 mg/kg) or SCH23,390 (1 mg/kg). Its bradycardic effect was antagonized only by metoclopramide (3 mg/kg). The hypotensive and bradycardic effects of clonidine (0.03 mg/kg) were most effectively antagonized by yohimbine (0.3-3 mg/kg). These findings indicate that in anaesthetized rabbits after i.v. administration, talipexole may lower blood pressure by peripheral, and heart rate by central, dopamine D2 agonism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104317     DOI: 10.1007/bf00168537

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  The interaction between prazosin and clonidine at alpha-adrenoceptors in rats and cats.

Authors:  P B Timmermans; E Lam; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1979-04-01       Impact factor: 4.432

2.  Modulation of motor activity by alpha 1- and alpha 2-adrenoceptor stimulation in mice.

Authors:  L Pichler; W Kobinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

3.  Investigation into different types of post- and presynaptic alpha-adrenoceptors at cardiovascular sites in rats.

Authors:  W Kobinger; L Pichler
Journal:  Eur J Pharmacol       Date:  1980-08-08       Impact factor: 4.432

4.  Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.

Authors:  H Schmitt; S Fénard
Journal:  Arzneimittelforschung       Date:  1973-01

5.  Lisuride-induced mounting and its modification by drugs active on adrenergic and dopaminergic receptors.

Authors:  F Ferrari; G Baggio; V Mangiafico
Journal:  Pharmacol Res Commun       Date:  1986-12

6.  Binding of an imidazolidine (clonidine), an oxazoloazepin (B-HT 933) and a thiazoloazepin (B-HT 920) to rat brain alpha-adrenoceptors and relation to cardiovascular effects.

Authors:  R Hammer; W Kobinger; L Pichler
Journal:  Eur J Pharmacol       Date:  1980-04-04       Impact factor: 4.432

7.  Central cardiovascular alpha-adrenoceptors. Relation to peripheral receptors.

Authors:  W Kobinger; C Lillie; L Pichler
Journal:  Circ Res       Date:  1980-06       Impact factor: 17.367

8.  The putative dopamine autoreceptor agonist B-HT 920 decreases nigral dopamine cell firing rate and prolactin release in rat.

Authors:  E Eriksson; K Svensson; D Clark
Journal:  Life Sci       Date:  1985-05-13       Impact factor: 5.037

9.  Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors.

Authors:  N E Andén; M Grabowska-Andén
Journal:  Acta Physiol Scand       Date:  1988-10

10.  Analysis of the effects of bromocriptine on blood pressure and sympathetic nerve function.

Authors:  M F Lokhandwala
Journal:  Eur J Pharmacol       Date:  1979-06-15       Impact factor: 4.432

View more
  1 in total

Review 1.  The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.

Authors:  P Ernsberger; J E Friedman; R J Koletsky
Journal:  J Hypertens Suppl       Date:  1997-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.